StockData
Curanex Pharmaceuticals Inc logo

Curanex Pharmaceuticals Inc (CURX) stock

CURXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$4.70−0.00 (-0.00%)

Close on Nov 18, 2026Market cap $7.37MP/E –Yield –

Curanex Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Curanex Pharmaceuticals's market cap was $160.54M on Nov 11, 2026, against $276.21M a year earlier.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$160.54M-14.3%
2025Dec 31, 2025$187.39M–

More Curanex Pharmaceuticals figures

See a number that looks wrong?